Cargando…
Magnetic Resonance Imaging Markers for Cognitive Impairment in Parkinson’s Disease: Current View
Cognitive impairment (CI) ranging from mild cognitive impairment (MCI) to dementia is a common and disturbing complication in patients with Parkinson’s disease (PD). Numerous studies have focused on neuropathological mechanisms underlying CI in PD, along with the identification of specific biomarker...
Autores principales: | Hou, Yanbing, Shang, Huifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821910/ https://www.ncbi.nlm.nih.gov/pubmed/35145396 http://dx.doi.org/10.3389/fnagi.2022.788846 |
Ejemplares similares
-
Multimodal magnetic resonance imaging on brain structure and function changes in vascular cognitive impairment without dementia
por: Zhang, Qinhong, et al.
Publicado: (2023) -
Self-Stigma in Parkinson's Disease: A 3-Year Prospective Cohort Study
por: Lin, Junyu, et al.
Publicado: (2022) -
Multiomics Analysis of Structural Magnetic Resonance Imaging of the Brain and Cerebrospinal Fluid Metabolomics in Cognitively Normal and Impaired Adults
por: Eldridge, Ronald C., et al.
Publicado: (2022) -
Regional Homogeneity in Patients With Mild Cognitive Impairment: A Resting-State Functional Magnetic Resonance Imaging Study
por: Wu, Yu-Qian, et al.
Publicado: (2022) -
Corrigendum: Regional homogeneity in patients with mild cognitive impairment: A resting-state functional magnetic resonance imaging study
por: Wu, Yu-Qian, et al.
Publicado: (2022)